Document is current

Any future updates will be listed below

POU5F1B is responsible for the acquired resistance to dabrafenib in papillary thyroid cancer cells with the BRAF V600E mutation

Crossref DOI link: https://doi.org/10.1007/s12020-024-03994-y

Published Online: 2024-08-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark